(19)
(11) EP 4 824 797 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24834184.4

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
G16B 20/20(2019.01)
G16B 40/00(2019.01)
G16B 30/10(2019.01)
(52) Cooperative Patent Classification (CPC):
G16B 20/20; G16B 30/10; G16B 40/00
(86) International application number:
PCT/US2024/060226
(87) International publication number:
WO 2025/129133 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 15.12.2023 US 202363611005 P
26.01.2024 US 202463625830 P
30.05.2024 US 202463653945 P

(71) Applicant: Illumina, Inc.
San Diego, CA 92122 (US)

(72) Inventors:
  • SCHEFFLER, Konrad Haarhoff
    San Diego, California 92122 (US)
  • BILKE, Sven
    San Diego, California 92122 (US)
  • LIU, Li
    San Diego, California 92122 (US)

(74) Representative: Lowden, Samuel Robert James 
Marks & Clerk LLP 2nd Floor Wytham Court 11 West Way
Oxford OX2 0JB
Oxford OX2 0JB (GB)

   


(54) MINIMAL RESIDUAL DISEASE (MRD) MODELS FOR DETERMINING LIKELIHOODS OR PROBABILITIES OF A SUBJECT COMPRISING CANCER